6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists

Journal of Medicinal Chemistry

Volumn 39, Issue 23, 1996, Pages 4667-4675

  Jiang, Ji Long ^a   Van Rhee, A Michiel ^a   Melman, Neli ^a   Ji, Xiao Duo ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 ETHYL 5 BENZYL 2 METHYL 4 [2 PHENYLVINYL] 6 PHENYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; 3 ETHYL 5 BENZYL 2 METHYL 4 PHENYLETHYNYL 6 PHENYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; 6 PHENYL 1,4 DIHYDROPYRIDINE DERIVATIVE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; CALCIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR CLONING; NONHUMAN; OXIDATION; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL LINE; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; DIHYDROPYRIDINES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1; RECOMBINANT PROTEINS;

EID: 0029824179     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960457c     Document Type: Article

References (32)

1. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7432-7436.
2. 3 receptors - pharmacological properties, species -differences and receptor functions. Trends Pharmacol. Sci. 1994, 15, 298-306.
3. 3-adenosine receptors: Mediation of behavioral depressant effects. FEBS Lett. 1993, 336, 57-60.
4. 3 adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 1995, 20, 689-699.
5. Stiles, G. L. Adenosine receptor subtypes: New insights from cloning and functional studies. Wiley: New York, in press.
6. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors - pharmacology, structure activity relationships, and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
7. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 1995, 115, 945-952.
8. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 1993, 268, 16887-16890.
9. Sajjadi, F. G.; Takabayashi, K.; Foster, A. C.; Domingo, R. C.; Firestein, G. S. Inhibition of TNF-α expression by adenosine. J. Immunol. 1996, 156, 3435-3442.
10. 3 receptors in mast-cells. Trends Pharmacol. Sci. 1994, 15, 13-14.
11. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 1994, 263, 59-67.
12. 3 receptor agonists. Biochem. Biophys. Res. Commun. 1996, 219, 904-910.
13. 3 receptor. Cancer Res. 1994, 54, 3521-3526.
14. Triggle, D. J. Drugs acting on ion channels and membranes. In Comprehensive Medicinal Chemistry; Emmett, J. C., Ed.; Pergamon Press: London, 1985; Vol. 3, pp 1047-1099.
15. Hu, P. S.; Lindgren, E.; Jacobson, K. A.; Fredholm, B. B. Interaction of dihydropyridine calcium channel agonists and antagonists with adenosine receptors. Pharmacol. Toxicol. 1987, 61, 121-125.
16. 3 receptors. J. Med. Chem. 1996, 39, 2980-2989.
17. Sorkin, E. M.; Clissold, S. P. Nicardipine: A review of its pharmacological and pharmacokinetic properties and therapeutic efficacy, in the treatment of angina pectoris, hypertension, and related cardiovascular disorders. Drugs 1987, 33, 296-345.
18. Stout, D. M.; Myers, A. I. Recent advances in the chemistry of dihydropyridines. Chem. Rev. 1982, 82, 223-243.
19. Singer, A.; McElvain, S. M. 2,6-Dimethylpyridine. Org. Synth. 1934, 14, 30-33.
20. Rathke, M. W.; Deitch, J. The reaction of lithium ester enolates with acid chlorides. A convenient procedure for the preparation of β-keto esters. Tetrahedron Lett. 1971, 31, 2953-2956.
21. Straley, J. M.; Adams, A. C. Ethyl benzoylacetate. Organic Syntheses; Wiley: New York, 1963; Collect. Vol. IV, pp 415-417.
22. Celerier, J.-P.; Deloisy, E.; Kapron, P.; Lhommet, G.; Maitte, P. Imidate Chemistry. Synthesis 1981, 130-133.
23. Braude, E. A.; Hannah, J.; Linstead, R. Hydrogen transfer. Part XVI. Dihydrides of nitrogenous heterocycles as hydrogen donors. J. Chem. Soc. 1960, 3249-3257.
24. 6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch. Pharmacol. 1989, 313, 179-187.
25. 2 receptors in rat brain tissue. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
26. 3 adenosine receptor. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10365-10369.
27. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
28. 3 adenosine receptor antagonists, J. Med. Chem. 1996, 39, 2293-2301.
29. Siddiqi, S. M.; Ji, X. D.; Melman, N.; Olah, M. E.; Jain, R.; Evans, P.; Glashofer, M.; Padgett, W. L.; Cohen, L. A.; Daly, J. W.; Stiles, G. L.; Jacobson, K. A. A survey of non-xanthine derivatives as adenosine receptor ligands. Nucleosides Nucleotides 1996, 15, 693-718.
30. 2-selective adenosine antagonists. J. Med. Chem. 1993, 36, 1333-1342.
31. Nonaka, Y.; Shimada, J.; Nonaka, H.; Koike, N.; Aoki, N.; Kobayashi, H.; Kase, H.; Yamaguchi, K.; Suzuki, F. Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine. J. Med. Chem. 1993, 36, 3731-3733.
32. 50) of an enzyme reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.